Bellevue, Washington–(business wire)– Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (“Company” or “Novo”) and Novo’s wholly-owned subsidiary, Clinical Consultants International (“CCI”), today announced the execution of a distribution agreement Did. A consulting agreement (“Agreement”), including potential revenue sharing, with Tranquility Lifestyle Solutions, Inc. (“TLS”), a company that has developed a technology platform that adds a new dimension to both senior wellness and senior wellbeing. Keeping families and caregivers notified of detected abnormalities very quickly complements Novo’s holistic approach to patient-first health and wellness.
The TLS platform will link the Vayyar 4D Radar Fall Detection Sensor and a host of other 4D radar and IOT devices to the cloud-based TLS platform in seniors’ homes or within the living environment of the senior community. The TLS platform uses machine learning and AI-based algorithms to generate alerts and send them to family and caregiver mobile applications. When an anomaly is detected, a push notification is sent to relevant mobile devices within 90 seconds, enabling timely deployment of medical assistance. In addition, the TLS platform also covers vital signs monitoring, presence detection, and cognitive enhancement without the use of cameras, listening devices, wearables, or personal activation.
Novo Chief Medical Officer Joseph M. Chalil, MD, MBA, FACHE, said: medical center. To date, his successful collaboration with CCI and Tranquility has already launched his two separate pilot projects with a US-based senior housing network and a US tertiary care hospital “Smart ICU Pilot”. .
About Tranquility Lifestyle Solutions
Founded in 2018, TLS helps elderly or elderly people living independently live or We provide customized solutions for providing high-quality home care to seniors living in residential care facilities. TLS’s individual platform love and their security.
TLS’s fall detection technology is based on non-intrusive and non-intrusive 4D radar sensors that provide quick notification via a communication platform and enable early intervention in the event of a fall. Smart, discreet and touchless, the TLS platform ensures instant protection, enhanced safety and health monitoring for seniors. At the core of our 4D Imaging Radar solution is an advanced and highly integrated 4D Imaging Radar on Chip (RoC) with all digital and analog RF components. These components include integrated digital signal processors (DSPs) and MCUs for complex signal and image processing. Additionally, working in conjunction with the Neteera Respiratory Module, the TLS platform can deploy unique sensing capabilities that can interpret salient vital signs such as heart rate and respiration rate. This sensing capability then interacts with his TLS platform to extract a collection of data that can inform individuals of their well-being trends. For more information on TKS, please visit www.tls.global.
About Clinical Consultants International LLC
Founded in 2006 as a hospital consulting firm in Michigan, Clinical Consultations International currently operates in pharmaceutical, biotechnology, healthcare administration, hospital administration, medical marketing and strategic planning, health policy, and value-added services for healthcare. A global consulting firm specializing in device sector. Headquartered in Boca Raton, Florida, we leverage over 30 years of industry experience and expert consultants around the world to support our clients. For more information on CCI, please visit www.ccimia.com.
About Novo Integrated Sciences
Novo Integrated Sciences, Inc. pioneers a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and consumer touchpoints for service and product innovation. I’m here. Through the integration of medical technology, diagnostic and therapeutic solutions, and rehabilitation science, Novo offers essential and differentiated solutions that provide or will provide these services and products.
We believe that the “decentralization” of healthcare through the integration of medical technology and interconnectivity is an essential solution to the rapidly evolving and fundamental transformation of how non-disruptive healthcare is delivered today and in the future. believe. Ongoing advances in both medical technology and interconnection, unique to non-critical care, are moving the patient-practitioner relationship into the patient’s home, away from field visits to major medical centers that provide large-scale services. You can keep away. This accelerated “accessibility” in patient/practitioner interaction for non-critical care diagnosis and subsequent treatment minimizes the progression from non-critical health conditions to critical conditions. It not only saves money but also enables more cost-effective healthcare delivery.
Our decentralized healthcare business model is focused on three key pillars to best support the transformation of non-disruptive healthcare delivery to patients and consumers.
Pillar 1: Service Network. Through clinic facilities operated through franchise relationships with (i) affiliate networks of clinic facilities, (ii) small and micro-footprint sized clinic facilities primarily within the footprint of box store commercial enterprises, (iii) Provide interdisciplinary primary care services. Company; and (iv) clinic facilities operated by Company.
Pillar 2: Technology. Develop, deploy and integrate sophisticated interconnection technologies to connect patients and healthcare professionals in geographies that cannot easily deliver advanced perimeter-based healthcare services, including patient care, beyond traditional clinic locations Expand the scope and availability of our services to a wider range of areas. House.
Pillar 3: Products. We develop and distribute effective, personalized health and wellness product solutions, enabling the customization of preventive care regimens for patients, ultimately enabling healthier people. Our science-first approach to product innovation further underscores our mission to create and deliver over-the-counter preventive and maintenance care solutions.
Innovation through science combined with the integration of sophisticated and safe technologies ensures Novo Integrated Sciences continues to make cutting-edge advances in its patient-first platform.
For more information on Novo Integrated Sciences, please visit: www.novointegrated.comFor more information on Novo Healthnet Limited, a wholly-owned subsidiary of Novo, please visit www.novohealthnet.com. www.novohealthnet.com
twitterLinkedIn, Facebook, Instagram, YouTube
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact contained in this press release are forward-looking statements. In some cases, forward-looking statements may include words such as “believe,” “intend,” “expect,” “predict,” “plan,” “may,” and “continue.” It can be identified by similar expressions. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. There are factors. These factors, risks and uncertainties are described in Novo’s filings with the Securities and Exchange Commission. Investors should not place undue reliance on forward-looking statements. These statements involve known and unknown uncertainties and, in some cases, other factors beyond Novo’s control, which could materially affect actual results, levels of activity and performance. and can have real impact. Or achievement. Forward-looking statements reflect Novo’s current views regarding future events and are subject to the impact of these and other risks, uncertainties and assumptions relating to its management, results of operations, growth strategy and liquidity. receive. Novo undertakes no obligation to publicly update or revise these forward-looking statements, even if new information becomes available in the future, or that actual results may differ materially from those anticipated in these forward-looking statements. We undertake no obligation to update reasons that may differ. The contents of websites referenced in this press release are not incorporated herein by reference.